| Lawyer | Section | Practice Area | Location |
|---|---|---|---|
| Korpus, Sheron | Non-IP Litigation & Enforcement | Antitrust | New York City |
| Toney, Jeffrey | Intellectual Property | General Patent Litigation, Hatch-Waxman Patent Litigation | Atlanta |
| , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} |
Non-IP Litigation & Enforcement
A New York litigation shop that has freed itself to take on disputes of any variety on behalf of plaintiffs or defendants, Kasowitz Benson Torres has been, and continues to be, a name synonymous with hard-charging litigation against financial institutions.
It has, however, made considerable strides in the life sciences realm via its representation of Teva and its US subsidiary Actavis. Sheron Korpus is defending numerous antitrust class actions consolidated in an MDL in the Eastern District of Pennsylvania that allege price-fixing of 18 generic drugs, and an antitrust action alleging price-fixing of two generic drugs brought by 40 States Attorneys General in the District of Connecticut.